All stock lists
Nuveen Municipal High Income Opportunity Fund (NMZ)
NYSE: NMZ · Real-Time Price · USD
Financial Services · Asset Management
8.76+0.13 (+1.45%)
Market cap
$1.89B
Website
Insider Score
––Not scored
NMZ Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
NMZ Income Statement
| Fiscal Period | Q2 2026 | Q4 2025 | Q2 2025 | Q4 2024 | Q2 2024 | Q4 2023 |
|---|---|---|---|---|---|---|
| Period Ending | Apr 30, 2026 | Oct 31, 2025 | Apr 30, 2025 | Oct 31, 2024 | Apr 30, 2024 | Oct 31, 2023 |
| Revenue | 46.25 M | 49.92 M | 46.39 M | 48.68 M | 43.20 M | 49.63 M |
| Revenue Growth (YoY) | 7.06 % | 0.59 % | -11.05 % | 274.65 % | 58.14 % | 33.77 % |
| Cost of Revenue | 6.72 M | 6.36 M | 6.58 M | 6.78 M | 6.46 M | 6.33 M |
| Gross Profit | 39.53 M | 43.56 M | 39.81 M | 41.89 M | 218.31 M | 49.63 M |
| SG&A Expense | 0.00 | 0.00 | 0.00 | -36.79 M | 176.17 M | 7.01 M |
| R&D Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 12.77 M | -33.11 M | 61.21 M | -36.79 M | 38.20 M | 7.01 M |
| Operating Income | 26.76 M | 76.67 M | -21.40 M | 78.68 M | 212.92 M | 42.62 M |
| Pretax Income | 13.36 M | 63.14 M | -36.90 M | 61.63 M | 197.16 M | -155.86 M |
| Tax Provision | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | 13.36 M | 63.14 M | -36.90 M | 61.63 M | 197.16 M | -155.86 M |
| EPS (Basic) | 0.06 | 0.55 | -0.33 | 0.55 | 1.78 | -1.41 |
| EPS (Diluted) | 0.06 | 0.55 | -0.33 | 0.55 | 1.78 | -1.41 |
| Shares Outstanding | 215.37 M | 114.11 M | 111.82 M | 111.63 M | 110.54 M | 221.08 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.
